Insys Execs Put 'Profits Over Patients,' Feds Tell Jury
As a 10-week racketeering conspiracy trial reached closing arguments Thursday, federal prosecutors sought to convince a Boston jury that former executives at Insys Therapeutics exploited vulnerable patients by bribing doctors to...To view the full article, register now.
Already a subscriber? Click here to view full article